The abstract describes a study investigating the synergistic anti-tumor efficacy and mechanism of ultrasound stimulated microbubbles cavitation (USMC) combined with PD-L1 antibody for enhancing immune checkpoint blockade therapy. The study was conducted on tumor-bearing mice divided into four groups: Control, USMC, anti-PD-L1, and USMC+anti-PD-L1. The results showed that the combination therapy achieved greater tumor growth inhibition and longer survival than the other groups. The study explored the synergistic mechanisms of combination therapy in four aspects: increased delivery of PD-L1 antibody in tumors; promotion of tumor vascular normalization; improvement of immune microenvironment; and amelioration of tumor hypoxia. The study concludes that the perfusion enhancement effect produced by USMC could be an effective method for enhancing PD-L1 antibody tumor therapy. The abstract is well-structured, provides sufficient details on the study methods and results, and presents a clear conclusion. However, it would benefit from more concise language and a clearer presentation of the study's significance

please evaluate the following abstract Aims To investigate the synergistic anti-tumor efficacy and mechanism of perfusion enhancement effect by ultrasound stimulated microbubbles cavitation USMC combi

原文地址: https://www.cveoy.top/t/topic/gwuc 著作权归作者所有。请勿转载和采集!

免费AI点我,无需注册和登录